Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00488
|
|||||
| Drug Name |
Benzylpenicillin
|
|||||
| Synonyms |
6-(2-Phenylacetamido)penicillanic acid; 61-33-6; Bencilpenicilina; Benzopenicillin; Benzyl penicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin G; Benzylpenicilline; Benzylpenicillinic acid; Benzylpenicillinum; Cilloral; Cilopen; Compocillin G; Cosmopen; Dropcillin; Free benzylpenicillin; Free penicillin G; Free penicillin II; Galofak; Gelacillin; Liquacillin; Pencillin G; Penicilling; Pfizerpen; Pharmacillin; Phenylacetamidopenicillanic acid; Pradupen; Specilline G; Ursopen
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Gram-positive bacteria infections [ICD11: 1A00-1H0Z] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H18N2O4S
|
|||||
| Canonical SMILES |
CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
|
|||||
| InChI |
InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1
|
|||||
| InChIKey |
JGSARLDLIJGVTE-MBNYWOFBSA-N
|
|||||
| CAS Number |
CAS 1110-47-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 334.4 | Topological Polar Surface Area | 112 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
1.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
11335491
, 11360730
, 11363827
, 11366389
, 11368951
, 11371783
, 11374081
, 11377113
, 11461702
, 11467106
, 11468226
, 11484211
, 11486734
, 11488334
, 11490358
, 11492286
, 11494747
, 14875396
, 15348041
, 26711903
, 29215263
, 29224931
, 46506778
, 47291043
, 47365102
, 47588906
, 47736376
, 48035012
, 48184904
, 48184905
, 49647119
, 50050765
, 53787815
, 57323037
, 57588014
, 617709
, 7849395
, 7885
, 7889969
, 79379468
, 7980271
, 81066337
, 81093162
, 8144852
, 8153657
, 820202
, 841337
, 85244562
, 85788897
, 85789209
|
|||||
| ChEBI ID |
ChEBI:18208
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [2] | |
| OATP1B1 | Transporter Info | Organic anion transporting polypeptide 1B1 | Substrate | [3] | ||
| OATP1B3 | Transporter Info | Organic anion transporting polypeptide 1B3 | Substrate | [4] | ||
| OATP2B1 | Transporter Info | Organic anion transporting polypeptide 2B1 | Substrate | [5] | ||
| OATP3A1 | Transporter Info | Organic anion transporting polypeptide 3A1 | Substrate | [5] | ||
| OATP4A1 | Transporter Info | Organic anion transporting polypeptide 4A1 | Substrate | [5] | ||
| PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [6] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT03632642) Penicillin Against Flucloxacillin Treatment Evaluation | |||||
| 2 | Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments. Drug Metab Dispos. 2011 Jun;39(6):1031-8. | |||||
| 3 | Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81. | |||||
| 4 | Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci. 2006 May;91(1):140-9. | |||||
| 5 | Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60. | |||||
| 6 | Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev. 2006 Nov 15;58(11):1136-63. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.